- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PolyPeptide Group AG (PPGN)
PolyPeptide Group AG stock price live, this page displays SIX PPGN stock exchange data. View the PPGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PolyPeptide Group AG real time stock price chart below.
What Is the PolyPeptide Group AG Stock Price Today?
The PolyPeptide Group AG stock price today is 44.00.
What Is the Stock Symbol for PolyPeptide Group AG?
The stock ticker symbol for PolyPeptide Group AG is PPGN.
Is PPGN the Same as $PPGN?
$PPGN is a common way to refer to the PolyPeptide Group AG ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does PolyPeptide Group AG Trade On?
PolyPeptide Group AG is listed and trades on the Switzerland stock exchange.
Is PolyPeptide Group AG a Good Stock to Buy?
Determining whether PolyPeptide Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current PolyPeptide Group AG share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PPGN quote. (ISIN: CH1110760852)
What Is the PolyPeptide Group AG Stock Price Today?
The PolyPeptide Group AG stock price today is 44.00.
What Is the Stock Symbol for PolyPeptide Group AG?
The stock ticker symbol for PolyPeptide Group AG is PPGN.
Is PPGN the Same as $PPGN?
$PPGN is a common way to refer to the PolyPeptide Group AG ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does PolyPeptide Group AG Trade On?
PolyPeptide Group AG is listed and trades on the Switzerland stock exchange.
Is PolyPeptide Group AG a Good Stock to Buy?
Determining whether PolyPeptide Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current PolyPeptide Group AG share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PPGN quote. (ISIN: CH1110760852)
Switzerland
Currency in CHF
44.00
+0.05(+0.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.95
44.05
52 wk Range
21.80
50.10
PPGN is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.9544.05
52 wk Range
21.8050.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PPGN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
39.20
Downside
-10.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High return over the last year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Analyst Ratings
4 Buy
1 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 39.20
(-10.92% Downside)
PolyPeptide Group AG Earnings Call Summary for H1/2026
- PolyPeptide H1 2026 revenue surged 41.6% YoY to EUR 236.6M; EBITDA jumped elevenfold to EUR 49.1M with margin expanding to 20.7% from 2.7%.
- Metabolics revenue drove growth, rising 72.6% YoY to represent 68% of total sales; phase III pipeline expanded to 37 projects, ~53% of global activity.
- Company raised FY 2026 revenue growth guidance to 25-30% from 20-25%; EBITDA margin expected in mid-to-high teens with capex at 15-20% of revenue.
- Braine facility now at target utilization; Strasbourg ramp-up begins H2 2026, Malmö commissioning underway with both contributing mainly in 2027.
- Management reaffirmed mid-term goal to double 2023 revenue by 2028; Samsung Biologics acquisition remains pending with no material competitive changes noted.
Last Updated: 08/13/2026, 04:23 AM
Read Full TranscriptPolyPeptide Group AG investor slides for H1/2026
Last Update: Aug 13, 2026
See full investor slides
Earnings
Latest Release
Mar 12, 2026
EPS / Forecast
0.16 / --
Revenue / Forecast
222.23M / --
Compare PPGN to Peers and Sector
Metrics to compare | PPGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPPGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | - | −1.1x | −0.4x | |
PEG Ratio | 8.97 | −0.01 | 0.00 | |
Price / Book | - | 1.9x | 2.6x | |
Price / LTM Sales | - | 1.8x | 3.1x | |
Upside (Analyst Target) | −9.0% | 16.6% | 48.4% | |
Fair Value Upside | Unlock | −1.9% | 6.5% | Unlock |
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the PolyPeptide Group AG (PPGN) Stock Price Today?
The PolyPeptide Group AG stock price today is 44.00 CHF.
What Stock Exchange Does PolyPeptide Group AG Trade On?
PolyPeptide Group AG is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for PolyPeptide Group AG?
The stock symbol for PolyPeptide Group AG is "PPGN."
What Is the PolyPeptide Group AG Market Cap?
As of today, PolyPeptide Group AG market cap is 1.45B CHF.
What Is PolyPeptide Group AG's Earnings Per Share (TTM)?
The PolyPeptide Group AG EPS (TTM) is -0.64.
From a Technical Analysis Perspective, Is PPGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has PolyPeptide Group AG Stock Split?
PolyPeptide Group AG has split 0 times.
How Many Employees Does PolyPeptide Group AG Have?
PolyPeptide Group AG has 1440 employees.
What is the current trading status of PolyPeptide Group AG (PPGN)?
As of Aug 14, 2026, PolyPeptide Group AG (PPGN) is trading at a price of 44.00 CHF, with a previous close of 44.00 CHF. The stock has fluctuated within a day range of 43.95 CHF to 44.05 CHF, while its 52-week range spans from 21.80 CHF to 50.10 CHF.
What Is PolyPeptide Group AG (PPGN) Price Target According to Analysts?
The average 12-month price target for PolyPeptide Group AG is 39.20 CHF, with a high estimate of 45.73330833 CHF and a low estimate of 25.9668042 CHF. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -10.92% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.